Skip to main content
. Author manuscript; available in PMC: 2012 Mar 1.
Published in final edited form as: Neuropharmacology. 2010 Dec 23;60(4):561–571. doi: 10.1016/j.neuropharm.2010.12.022

Fig. 4.

Fig. 4

Effect of restraint stress and selective CRF1 receptor blockade on baseline startle amplitude. Values shown are means ± SEMs and were calculated from the startle stimulus alone trials that were used to calculate percent PPI. Startle amplitude was assessed 30 minutes after restraint termination on days 1, 3, and 5. Neither pretreatment with CP-154,526 nor restraint altered startle amplitude.